VECTOR SUPPLIES LIMITED
Company number SC103810 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Financial Health Assessment: Vector Supplies Limited
1. Financial Health Score: B+
Explanation: Vector Supplies Limited presents as a financially robust patient with a strengthening balance sheet, excellent liquidity recovery, and consistent net asset growth. The slight decline in turnover and operating margins prevents a higher grade, but the underlying vital signs are reassuringly stable for a company operating in the volatile oil and gas sector.
2. Key Vital Signs
Balance Sheet Strength — 🟢 Healthy
| Metric | FY2025 | FY2024 | FY2023 | Trend |
|---|---|---|---|---|
| Net Assets | £4,154,767 | £3,792,795 | £3,316,147 | ↑ Consistent growth |
| Total Liabilities | £1,334,201 | £2,492,223 | £2,545,192 | ↓ Significant reduction |
| Net Current Assets | £4,177,857 | £3,806,501 | Not disclosed | ↑ Strong working capital |
Interpretation: The balance sheet is the corporate equivalent of a strong skeletal structure. Net assets have grown by approximately £362,000 year-on-year, and the company has aggressively paid down liabilities — reducing them by nearly £1.16 million in a single year. This is a patient paying down its debts and building reserves.
Cash Position — 🟢 Excellent Recovery
| Year | Cash | Change |
|---|---|---|
| FY2025 | £916,259 | +512% |
| FY2024 | £149,778 | +131% |
| FY2023 | £64,694 | -60% |
| FY2022 | £160,107 | -72% |
| FY2021 | £562,608 | Baseline |
Interpretation: Cash is the lifeblood of any business, and this patient's circulation has dramatically improved. After a concerning dip to £64,694 in FY2023 (a dangerously thin cash position for a company of this scale), the recovery to £916,259 is remarkable. This suggests either improved cash collection, reduced capital expenditure, or a deliberate strategy to build cash reserves against sector uncertainty.
Profitability — 🟡 Moderate
| Metric | FY2025 | FY2024 |
|---|---|---|
| Turnover | £12,302,648 | £13,794,049 |
| Operating Profit | £465,782 | £684,425 |
| Operating Margin | ~3.8% | ~5.0% |
Interpretation: Turnover declined by approximately 10.8%, and operating profit fell by nearly 32%. The operating margin has compressed from 5% to 3.8%. While the company remains profitable, this margin erosion is like a slightly elevated blood pressure reading — not immediately dangerous, but worth monitoring. The directors attribute this to market conditions and describe performance as still "strong."
Leverage & Solvency — 🟢 Healthy
- Debt-to-Equity Ratio: £1,334,201 / £4,154,767 = approximately 0.32:1
- Liabilities as percentage of total assets: ~24%
Interpretation: This is a conservatively financed business. Liabilities represent less than a quarter of total assets, and the debt-to-equity ratio is comfortably low. The patient is not over-leveraged.
3. Diagnosis
Primary Condition: Stable with encouraging recovery signs, but operating in a volatile environment
Strengths: - Robust liquidity transformation: The dramatic improvement in cash from £64,694 to £916,259 over two years demonstrates excellent cash management discipline. This is the financial equivalent of going from critically low blood pressure to a healthy reading. - Consistent net asset growth: Net assets have grown every year for the past four years (£3.12M → £2.97M → £3.32M → £3.79M → £4.15M), with only a minor dip in FY2022. Note: the FY2022 dip appears to reflect asset growth outpaced by liability increases, but net assets still remained positive. - Debt reduction: The company has reduced total liabilities by approximately £1.16 million in one year, suggesting either deliberate deleveraging or improved supplier payment terms. - No dividend drain: Zero dividends declared in both FY2024 and FY2025, meaning all profits are being retained to strengthen the business. This is prudent given sector volatility. - Strong net current assets: At £4,177,857, the company has excellent working capital to weather short-term disruptions.
Concerns: - Margin compression: Operating margin declining from 5% to 3.8% is a symptom worth watching. In the oil and gas supply sector, margins can be thin, and further erosion could threaten the company's ability to generate sufficient profit from its asset base. - Revenue decline: A 10.8% turnover drop is not catastrophic, but in an industry where fixed costs can be significant, revenue declines can disproportionately impact profitability. - Sector volatility: The directors explicitly acknowledge the "extremely volatile" nature of the oil and gas sector. This is an environmental risk factor — like a patient living in a polluted city — that is outside management's control but must be managed. - Currency exposure: While the directors state that foreign currency risk is "manageable" (transactions in Euros and US Dollars), this remains a risk factor that could impact margins if exchange rates move unfavourably. - Concentration risk: The company's PSC is Vector Supplies (Holdings) Limited, which owns more than 75% of shares and voting rights. While not unusual for a subsidiary, this means strategic decisions are ultimately controlled by the parent entity.
4. Prognosis
Short-term outlook (12 months): Favourable — The directors state they expect FY26 to deliver "similar numbers with regard to turnover and margin," suggesting stability rather than further decline. The strong cash position provides a comfortable buffer.
Medium-term outlook (2-3 years): Cautiously optimistic — Much depends on the oil and gas sector's trajectory. The company's balance sheet strength provides resilience, but the sector's structural challenges (energy transition, price volatility) remain headwinds.
Key risk: A prolonged downturn in the oil and gas sector could compress margins further. The current 3.8% operating margin leaves limited room for further erosion before profitability becomes a genuine concern.
5. Recommendations
-
Monitor margin health closely: With operating margins at 3.8%, implement regular monthly margin tracking. Like monitoring a chronic condition, early detection of further erosion allows for timely intervention — whether through cost reduction, pricing adjustments, or service mix optimisation.
-
Maintain cash reserves: The cash recovery to £916,259 is excellent. Resist the temptation to deploy this into excessive capital expenditure or dividend extraction. In a volatile sector, cash is your immune system — it protects against external shocks.
-
Revenue diversification assessment: While the directors note the company is "not reliant upon one geographical market," consider whether diversification into adjacent energy sectors (renewables, decommissioning services) could provide revenue stability and reduce sector-specific risk.
-
Foreign currency hedging review: While management considers currency exposure "manageable," a formal review of hedging strategies — even if the conclusion is to maintain the current approach — would demonstrate prudent risk management to stakeholders.
-
Working capital optimisation: With net current assets of £4.18M, investigate whether any surplus working capital could be deployed more efficiently, such as through short-term deposit accounts or reducing any expensive trade creditor financing.